Funded Startups in Providence
Across the 30 most recent Providence-area rounds shown (2020-09-21 through 2025-10-15), the disclosed amounts are highly uneven: Rhode Island Infrastructur…
Across the 30 most recent Providence-area rounds shown (2020-09-21 through 2025-10-15), the disclosed amounts are highly uneven: Rhode Island Infrastructure Bank’s $77M round on 2023-06-13 dwarfs the next-largest disclosed entries ($27M for Utilidata on 2022-02-08, $20M for Genesis Center on 2025-04-03, and $13M for Nabsys on 2022-11-09). The list also clusters into two temporal bands, with multiple rounds landing in late 2023 (e.g., Ocean Biomedical $10M on 2023-10-04; Looie $50K on 2023-08-01; Crossroads Rhode Island $70K on 2023-02-21) and again in 2024 (e.g., Intus Care $11M on 2024-11-14; HavocAI $12M on 2024-09-16). Sector and stage mix are similarly concentrated: Financial Services appears in 4 entries (Amos House, Beeline, Light Frame, Capital Good Fund), and “Series Unknown” is the most common classification (15 of 30 rows), while “undisclosed” appears in 3 rows (SiC Systems on 2025-10-15; Share Winter Foundation on 2024-11-02; Bolden Therapeutics on 2024-01-09). The smallest disclosed amount is $0K for Ri Bio on 2024-08-08, standing out as a disclosure-edge case versus the rest.
Most recent rounds
30 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Providence listing, and is it a true outlier?
Rhode Island Infrastructure Bank’s $77M on 2023-06-13 is the only disclosed amount above $50M in the visible rows, and it materially exceeds the next-largest disclosed entries: Utilidata ($27M, 2022-02-08) and Genesis Center ($20K, 2025-04-03) / Nabsys ($13M, 2022-11-09).
How concentrated are deal dates among the 30 most recent entries?
The table spans 2020-09-21 (Tugboat) through 2025-10-15 (SiC Systems). Within that window, there are visible bursts in 2024 (e.g., Intus Care $11M on 2024-11-14; HavocAI $12M on 2024-09-16; Beeline $580K on 2024-08-08) and another cluster in 2023 (e.g., Ocean Biomedical $10M on 2023-10-04; Looie $50K on 2023-08-01).
Which sectors appear often enough to matter, and which are thinly represented?
Financial Services is the clearest repeat with 4 entries (Amos House $1M on 2025-03-12; Beeline $580K on 2024-08-08; Light Frame $2M on 2024-05-29; Capital Good Fund $1M on 2024-04-05). Biotechnology shows up 3+ times as well (Ri Bio $0K on 2024-08-08; Ocean Biomedical $10M on 2023-10-04; Nabsys $13M on 2022-11-09; Bolden Therapeutics undisclosed on 2024-01-09).
What stage label dominates, and what share of rows are not stage-labeled?
“Series Unknown” appears in 15 of 30 rows, making it the dominant classification (e.g., Intus Care $11M on 2024-11-14; Amos House $1M on 2025-03-12; Ocean Biomedical $10M on 2023-10-04). Separately, 3 rows list “undisclosed” amounts (SiC Systems on 2025-10-15; Share Winter Foundation on 2024-11-02; Bolden Therapeutics on 2024-01-09).
Are there notable low-end or disclosure-edge outliers among disclosed amounts?
Ri Bio’s $0K on 2024-08-08 is the smallest disclosed amount in the dataset shown, which is distinct from the many sub-$100K rounds elsewhere (e.g., Genesis Center $20K on 2025-04-03; Looie $50K on 2023-08-01). On the high end, the $77M round (Rhode Island Infrastructure Bank, 2023-06-13) creates a long tail that makes most other disclosed rounds ($580K–$27M) cluster together by comparison.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.